Blue Horseshoe Stocks: Fresh PBR Options & More

Petroleo Brasileiro SA (Petrobras) PBR – Recap

One of the ideas we had formulated toward the end of last week was the PBR Weekly $14 & 14.50 Calls. We mentioned in Friday morning’s premarket report that we expected the already solid gains we had seen the previous session to be expanded upon, and our assumption was accurate.

We saw epic new highs out of both of our tracked sets of contracts. The $14 Calls from our observed low of .21 on Thursday, saw a new high of .78 Friday for a two-day run of 271% The $14.50′s, which we had caught at a low of .05, ran to .29 for an impressive 480% move over the same span.

Updated Idea:
We’re going to update our idea to some weekly calls for this week and roll up our strike range. Provided PBR can hold its 50DMA of 14.32, we’ll be looking to the PBR Weekly $14.50-15.50 Calls.



Extended Watchlist Recaps:

We’ve been doing things the same way for several years now, issuing our daily ‘Extended Watchlist’ for ideas that don’t get featured, but are stil noteworthy enough to keep watch over. Two such plays that we’ve recently signaled came away from last week with some decent progress.

Epizyme, Inc. EPZM – EPZM was included in Friday’s extended watchlist and it had a very nice intraday push, helped along by solid jobs numbers which led to a good day for the markets as a whole. EPZM traded in a range from 6.40 up to 8.19, a solid 28% jump.
____

Scientific Games Corp. SGMS – On December 14th we included SGMS in our premarket report, and it has made steady and significant headway since that time, trading up from a low of 14.79 to a new high of 19.43 on Friday. A 31% move in a stock in this price range is a pretty darn good move through a few weeks of the holiday season.  We’ll continue to keep an eye on this, which has become a solid momentum mover.


Extended Watchlist:
SAGE, INSM, QEP, ROKU, KEG, SPWR, AXSM, DXCM, SXTC,

Blue Horseshoe Stocks: PBR Options Recap & More

Petroleo Brasileiro SA (Petrobras) PBR – Recap

Yesterday morning, one of the primary focal points our premarket report was a pair of PBR options contracts, the PBR Weekly $14 & 14.50 Calls.

We cited the stock’s volatility and rapid rise over recent relative lows as the reasons for our interest, and despite yet another reversal for the markets in general, we got very solid single-session results for our PBR ideas. The $14′s traded up 95% from .21-.41, while the $14.50′s logged a double-bagger as they ran from  .05-.11, a gain of 120%

PBR is gapping up once again this morning, so we expect these figures to open up even higher. We will then be looking for a possible dip-and-rip scenario.


BioXcel Therapeutics, Inc. BTAI

We mentioned BTAI for the first time in yesterday morning’s extended watchlist, and got a solid first day performance from that stock as well, as it went in the books as the 2nd highest gainer on the Nasdaq for the session.

From a low of 4.00, BTAI went on to hit a high of 5.84, which worked out to a respectable 46% rise that also bucked the overall trend of the day. The move was facilitated by news that the company achieved positive human proof-of-concept data for acute treatment of agitation in patients with Alzheimer’s Disease, and other degenerative neural disorders. (>>View PR)


Extended Watchlist:
W, APU, ARGX, MYSZ, SN, XPO, EPZM, AMID, PROP, SING